Cellular and molecular mechanisms of synaptic dysfunction in parkinson's disease - synaptic and axonal terminal dysfunction of substantia nigra pars compacta (SNC) dopamine (DA) neurons are one the…

Active Grant Awarded

Award ID
R01AG101715
Recipient
Awarding agency
Obligated
$577,784

Award facts

Assistance listing
93.866 Aging Research
Completion date 4% complete
Place of performance
Chicago, IL 60611, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services' National Institutes of Health, through the National Institute on Aging, awarded Northwestern University $577,784 on September 9, 2026 under Assistance Listing 93.866, Aging Research, for grant R01AG101715. The grant funds research into synaptic dysfunction in the nigrostriatal pathway linked to LRRK2, one of the most common genetic causes of Parkinson's disease. The study uses LRRK2 G2019S knock-in mice to investigate deficits in dopamine release and axonal integrity in vulnerable substantia nigra pars compacta dopamine neurons. It applies a single-nucleus RNA sequencing classification of dopamine neuron subtypes and intersectional genetic models targeting distinct subclusters. The investigators hypothesize that heightened LRRK2 kinase activity aberrantly phosphorylates synaptic targets such as RAB3 proteins, affecting vesicular trafficking. Dollars obligated are $577,784. The period of performance runs from the September 9, 2026 award date to an ultimate completion date of August 31, 2031. Place of performance is Chicago, IL 60611. The program encourages biomedical, social, and behavioral research and training on the aging process and its diseases, with a particular emphasis on preventing and treating Alzheimer's disease and related dementias.

Description

Cellular and molecular mechanisms of synaptic dysfunction in parkinson's disease - synaptic and axonal terminal dysfunction of substantia nigra pars compacta (SNC) dopamine (DA) neurons are one the earliest manifestations during parkinson's disease (PD) that precedes the overt cell loss. Understanding the precise mechanisms that lead to axonal deficits could pave the way to early therapeutic intervention. The current study aims to investigate synaptic dysfunction in the nigrostriatal pathway related to LRRK2, which is one of the most common genetic causes of PD. Pathogenic mutations in LRRK2 increase its kinase activity and have been studied extensively across various models and cell types. However, how LRRK2 affects the integrity of vulnerable DA neurons and their axons has not been systematically studied, primarily due to technical limitations. Our preliminary data and published studies showed that LRRK2 knock-in (KI) mice expressing the most common pathogenic mutation G2019S (LRRK2G2019S) at physiological levels exhibit deficits in DA release, paralleled by increased phosphorylation of synaptic LRRK2 targets. Notably, these changes are more pronounced in the ventral tier SNC dopamine neurons, which are more vulnerable in PD, compared to those in the dorsal tier. The selective vulnerability of DA neurons prompted US to generate a high-resolution molecular classification schema of DA neurons by single-nucleus RNA sequencing. This knowledge enabled the development of intersectional genetic models to study distinct subclusters of DA neurons. Our data reveal remarkable functional heterogeneity across vulnerable and resilient SNC DA neurons and show higher LRRK2 expression in the vulnerable subtypes. We hypothesize that increased kinase activity of LRRK2 may lead to aberrant phosphorylation of synaptic targets in these neurons, such as RAB3 proteins, which directly affect their function, including vesicular trafficking. These impairments not only affect DA release but also disrupt a neurotrophic signaling pathway that is critical for DA neuron integrity and maintenance. Aim 1 of our study will examine cell-type-specific structural, functional, and molecular deregulations in identified vulnerable DA neuron synapses in young and aged LRRK2G2019S mice. In aim 2, we will connect the presynaptic alterations in DA axons to the disruption of a neuroprotective signaling loop for DA neurons. Since this mutation renders the kinase hyperactive, we will also investigate whether specific LRRK2 kinase inhibitors can restore the synaptic functions. Our research will investigate the effect of LRRK2G2019S on vulnerable DA neuron synapses, providing crucial insights into early disease mechanisms. By doing so, we aim to uncover new targets and pathways focused on the mostly unresolved LRRK2 pathobiology.

Quick answers

Who received award R01AG101715?

R01AG101715 was awarded to Northwestern University by National Institute on Aging (National Institutes of Health) on September 9, 2026.

How much is award R01AG101715 worth?

$577,784 has been obligated on R01AG101715.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award